11. May 2012 14:43
The ABPI Code of Practice is set to be amended to reflect changes to international guidelines and UK law.
Proposals for 17 amendments result from changes to the IFPMA governing code or are responses to the Human Medicines Regulations 2012.
Several of the amendments include minor adjustments to wording. However, additional proposals, including new clauses relating to pharma’s relations with patient groups, could be significant.
Clause 1 – Scope of the code and definition of certain terms – will see up to five amendments introduced with two modifications also suggested to Clause 2 and Clause 23.
If approved, they would be included in the Code and come into effect on 1 July 2012 before becoming fully operative on 1 November 2012.
As a member of the International Federation of Pharmaceutical Manufacturers and Associations, the ABPI is duty bound to bring its own regulations in line with that of the IFPMA.
The proposals have now been sent to member companies, relevant bodies and the Serious Fraud Office.